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Introduction
This experiment consisted of the controlled differentiation of H9 embryonic stem 
cells to mesenchymal stem cells. Though this experiment was repeated twice and 
improvement was seen in these repetitions, the cells were only able to be partially 
differentiated. However, the morphology of the differentiated cells is similar to 
those of healthy adult mesenchymal stem cells.
Method
When the H9 embryonic stem cells reached 50% confluency in E8 full medium, the 
differentiation process began. The H9 human embryonic stem cells were 
differentiated into mesenchymal stem cells by changing the well medium of the cells 
from E8 full medium to DMEM + 10% FBS + P/S. The medium was replaced every 
day during the entire differentiation process. When the cells in each well plate 
reached 90% confluency (Day 5), the cells were passaged by treating the cells with a 
0.25% trypsin and 0.1% EDTA solution, transferring the cells to a new well plate 
without Matrigel, and returning to the DMEM + 10% FBS + P/S solution medium. 
Cell growth continued until the wells reached 50% confluency, or at Day 17 where 
the cells were passaged for a second time. For the protocol for mesenchymal stem 
cell differentiation, the cells are to undergo four passages until the completion of the 
differentiation. 
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Results
The progression of the differentiation can be seen in the microscope slide photos 
below. Throughout the differentiation, there occurred a decrease in cell survival 
and reduction of cell growth, but an increase in mesenchymal stem cell 
morphology. Throughout the last week of the differentiation, very little cell growth 
was seen and the cells were fixed on Day 20. With this, the cells were unable to 
sustain survival and growth to complete the four passages required for complete 
mesenchymal stem cell differentiation. 
Discussion
As stated above, the mesenchymal stem cell differentiation was unable to go to 
completion as cell growth only allowed two passages. This protocol was 
performed twice, and the results discussed are of the second trial. The second 
trial yielded greater progress than the first, so more trials may yield better 
results or result in a complete differentiation. There are no targetable sources of 
error, but the medium was changed at different times during the day, so this 
inconsistency may result in cell agitation and death. Due to the similarity in 
morphology of the differentiating cells to the proper morphology of 
mesenchymal stem cells, there is supporting evidence that this protocol has the 
potential to produce healthy and proliferating mesenchymal stem cells.
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